Loading
永日
永日 Stock: price and insider trades · Taiwan
永日: what insiders have been doing
永日, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to TWSE / TPEx (MOPS). Between 20 October 2025 and 20 October 2026, 1 insider published 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
With 2 filings in twelve months, the company is in line with the median of 2 filings across the 620 companies we follow on the same exchange.
Over the last twelve months, not one insider purchase of 永日 stock was filed.
In the same sector, recent insider purchases at Vivos Inc and Anixa Biosciences Inc also feature in our signals. These figures are compiled from regulatory filings published by TWSE / TPEx (MOPS). They describe what insiders did and are not a recommendation.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 23,705 of 26,193 companies
21.3
score / 100
Value19
Quality24
FCF yld-5.8%
Earn yld-1.8%
EV/EBITDA34.0x
ROE0.6%
Gross mgn20%
Net mgn-3.0%
Debt/EBITDA5.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
NT$19
Analyst consensus
Income statement
RevenueNT$474.2M
Gross profitNT$94.6M20% margin
EBITDANT$28.2M6% margin
Net income-NT$14.4M-0.1% margin
Valuation
P/Book1.3x
Beta-0.08
Balance sheet & cash
Market capNT$800.9M
Total debtNT$157.4M
Free Cash Flow-NT$46.2M
Debt / Equity24%
Profitability & ownership
ROE0.6%
ROA-1.0%
% insiders40.9%
% institutions0.0%
Last declaration on 18 December 2025
Declarations5 total
399,000 sharesShareTPExTWMOPS:4102:114/12/18:永信國際投資控股股公司:0m1ycss
1,112,000 sharesShareTPExTWMOPS:4102:114/11/14:永信國際投資控股股公司:10d7r05
5 of 5 declarations
About 永日
永日 is a company listed on the XTAI market, specializing in various financial services.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations